Diabetes Clinical Trials in Miami, FL

70 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer	Phase 3	Energenesis Biomedical Co., Ltd.	<1 mi
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)	Phase 1	Merck Sharp & Dohme LLC	<1 mi
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations	N/A	Capsicure, LLC	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	<1 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	N/A	Piomic Medical	<1 mi
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes	Phase 1/2	Creative Medical Technology Holdings Inc	<1 mi
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)	Phase 2	Sanofi	<1 mi
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.	Phase 4	Royal Biologics	<1 mi
RESET System Pivotal Trial (Rev F)	N/A	Morphic Medical Inc.	<1 mi
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes	N/A	Endogenex, Inc.	<1 mi
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)	Phase 3	Pfizer	<1 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes	Phase 4	Brigham and Women's Hospital	<1 mi
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial	Phase 2	Jason Sperry	<1 mi
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)	Phase 1	Gilead Sciences	<1 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Prokidney	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes	Phase 1	Hua Medicine Limited	<1 mi
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy	N/A	Jaeb Center for Health Research	<1 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes	Phase 2	Novo Nordisk A/S	<1 mi
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.	N/A	Molnlycke Health Care AB	<1 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	<1 mi
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes	Phase 1/2	City of Hope Medical Center	<1 mi
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight	Phase 3	Eli Lilly and Company	<1 mi
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease	Phase 2	Regeneron Pharmaceuticals	<1 mi
Long Term Follow up of Recipients of Functional Islet Allografts	—	Rodolfo Alejandro	<1 mi
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes	Phase 2	Housey Healthcare ULC	<1 mi
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus	Phase 2	Sun Pharmaceutical Industries Limited	<1 mi
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye	Phase 1/2	Midhat H. Abdulreda	<1 mi
Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss	—	Rodolfo Alejandro	<1 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1D	Phase 1	GentiBio, Inc	<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency	Phase 1	Sun Pharmaceutical Industries Limited	<1 mi
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers	N/A	Tides Medical	<1 mi
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss	N/A	Rodolfo Alejandro	<1 mi
A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM	Phase 1/2	Alnylam Pharmaceuticals	<1 mi
Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers	N/A	LifeNet Health	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	<1 mi
ECHO Diabetes FQHC	—	University of Florida	<1 mi
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes	Phase 3	Vertex Pharmaceuticals Incorporated	<1 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)	—	Jaeb Center for Health Research	<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	<1 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	<1 mi
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D	Phase 1	Alveus Therapeutics, Inc.	<1 mi
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes	Phase 1	Eli Lilly and Company	<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
Clinical Applications of Advanced Ophthalmic Imaging	N/A	University of Miami	<1 mi
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer	Phase 1/2	Aulos Bioscience, Inc.	<1 mi
Trial to Assess Chelation Therapy in Critical Limb Ischemia	Phase 3	Mt. Sinai Medical Center, Miami	4 mi
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL	Phase 4	HealthTech Wound Care	11 mi
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets	Phase 2	Biomea Fusion Inc.	13 mi
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy	Phase 2	Biomea Fusion Inc.	13 mi
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome	Phase 3	NewAmsterdam Pharma	13 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes	Phase 3	vTv Therapeutics	13 mi
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring	—	Abbott Diabetes Care	13 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Hoffmann-La Roche	17 mi
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin	Phase 2	Eli Lilly and Company	17 mi
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers	Phase 4	Applied Biologics, LLC	17 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease	Phase 2	Novo Nordisk A/S	17 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes	Phase 3	Sanofi	17 mi
Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing	N/A	Reprise Biomedical, Inc.	31 mi
Study of WAL0921 in Patients With Glomerular Kidney Diseases	Phase 2	Walden Biosciences	31 mi
Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care	N/A	Reprise Biomedical, Inc.	31 mi
Neurologic Stem Cell Treatment Study	N/A	MD Stem Cells	36 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.